|
KMID : 1188320110050010077
|
|
Gut and Liver
2011 Volume.5 No. 1 p.77 ~ p.81
|
|
|
Antiviral Therapy in Patients after Treatment for Hepatitis C-Related Hepatocellular Carcinoma
|
|
Shin Su-Rin
Paik Seung-Woon
Gwak Geum-Youn
Choi Moon-Seok
Lee Joon-Hyoek
Koh Kwang-Cheol
Yoo Byung-Chul
|
|
|
Abstract
|
|
|
Background/Aims: Despite great progress, antiviral treatment for chronic hepatitis C in patients with prior hepatocellular carcinoma (HCC) has been rarely investigated. We evaluated the effi cacy and safety of antiviral therapy following treatment for hepatitis C-related HCC.
Methods: Thirteen patients (age 34 to 60 years) who were treated with peginterferon plus ribavirin after treatment for HCC were reviewed.
Results: There were 6 patients with genotype 1 and 7 patients with genotype 2. All patients showed advanced fi brosis (≥F3) but belonged to the Child-Pugh class A. Treatment was stopped in 2 patients because of recurrent HCC and in 1 patient due to a lack of early virologic response. Seven patients achieved sustained virologic response and three patients relapsed. The sustained virologic response rate was 54% overall, 17% in genotype 1, and 86% in genotype 2. No signifi cant adverse events were reported.
Conclusions: Antiviral therapy should not be excluded in patients who were previously treated with HCC with genotype 2 chronic hepatitis C, in which an effi cacious antiviral treatment for chronic hepatitis C was feasible. Additional study is needed to prove the validity of antiviral therapy in patients with genotype 1 hepatitis C-related HCC.
|
|
|
KEYWORD
|
|
|
Chronic hepatitis C, Hepatocellular carcinoma, Peginterferon, Ribavirin
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
   
|